Drug Shortage Report for TEVA-BUDESONIDE
| Report ID | 195478 |
| Drug Identification Number | 02465957 |
| Brand name | TEVA-BUDESONIDE |
| Common or Proper name | TEVA-BUDESONIDE |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | BUDESONIDE |
| Strength(s) | 0.5MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INHALATION INHALATION |
| Packaging size | 20 |
| ATC code | R03BA |
| ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-06-19 |
| Estimated end date | 2025-11-30 |
| Actual end date | 2025-11-28 |
| Shortage status | Resolved |
| Updated date | 2025-12-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v91 | 2025-12-02 | French | Compare |
| v90 | 2025-12-02 | English | Compare |
| v89 | 2025-11-27 | French | Compare |
| v88 | 2025-11-27 | English | Compare |
| v87 | 2025-10-23 | French | Compare |
| v86 | 2025-10-23 | English | Compare |
| v85 | 2025-09-18 | French | Compare |
| v84 | 2025-09-18 | English | Compare |
| v83 | 2025-09-04 | French | Compare |
| v82 | 2025-09-04 | French | Compare |
| v81 | 2025-09-04 | French | Compare |
| v80 | 2025-09-04 | English | Compare |
| v79 | 2025-09-04 | English | Compare |
| v78 | 2025-08-28 | French | Compare |
| v77 | 2025-08-28 | English | Compare |
| v76 | 2025-08-21 | French | Compare |
| v75 | 2025-08-21 | English | Compare |
| v74 | 2025-08-08 | French | Compare |
| v73 | 2025-08-08 | English | Compare |
| v72 | 2025-07-10 | French | Compare |